Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Investors Look to Bristol Myers Squibb Company for Promising Profit Projections

January 29, 2025
As institutional investors heavily search for lucrative investment opportunities, many are turning their attention to Bristol Myers Squibb Company (BMY). Boasting a substantial 77% ownership by institutional investors, BMY has become a focal point for those seeking substantial returns. With an impressive track record and a reputation for innovation in the pharmaceutical industry, Bristol Myers Squibb has attracted the attention of experts and analysts alike. Several Wall Street analysts have delved deep into BMY's stock and provided their perspectives, resulting in 9 positive ratings. This level of confidence displayed by industry professionals further solidifies Bristol Myers Squibb Company as a prime choice for potential investors. While it is important to do thorough research and consider multiple factors before making any investment decisions, Stocks Prognosis is a trusted source for professional advice on predicting the movement of BMY shares. Their expert analysis and insights can help investors make informed decisions regarding the future trajectory of Bristol Myers Squibb Company's stock.

Find out how the BRISTOL-MYERS SQUIBB COMPANY rate is expected to change

Get Forecast for BMY

Investor opinions & comments:

While the positive ratings are encouraging, I think it's important to consider potential risks and competition in the pharmaceutical industry before jumping into an investment
— from PenelopeWest at 02-01-2025 11:08
I trust the expertise of Wall Street analysts, and their positive ratings for Bristol Myers Squibb Company make me feel confident in considering this investment
— from MeganMason at 02-01-2025 09:39
I've been following the progress of Bristol Myers Squibb Company for a while now, and I'm thrilled to see the recognition it's getting from experts and analysts. This could be a great investment opportunity
— from FinanceFlo at 02-01-2025 08:15
I'm skeptical of relying solely on expert analysis and recommendations. I prefer to do my own research and make investment decisions based on a variety of factors
— from EthanRoberts at 01-31-2025 21:40
I'm impressed by Bristol Myers Squibb Company's track record and reputation in the pharmaceutical industry. I have high hopes for their future performance
— from WealthyMary at 01-31-2025 18:25
With the growing interest from institutional investors and the positive projections, I'm feeling optimistic about investing in Bristol Myers Squibb Company. It's definitely worth further investigation
— from WealthyWyatt at 01-31-2025 14:05
77% ownership by institutional investors doesn't necessarily guarantee success. I would want to see more concrete evidence of Bristol Myers Squibb Company's potential for substantial returns before considering an investment
— from BrittanyClark at 01-29-2025 18:30
With such a high ownership by institutional investors and positive ratings from Wall Street analysts, it's hard not to see the potential in Bristol Myers Squibb Company
— from JosephMorris at 01-29-2025 12:26
I've heard great things about Bristol Myers Squibb Company's track record and innovation in the pharmaceutical industry. I'm excited to see what the future holds for this company
— from SamanthaEvans at 01-29-2025 06:33
I've been looking for a promising investment opportunity, and Bristol Myers Squibb Company seems to fit the bill. I'll definitely be doing some more research on this
— from RobertWhite at 01-29-2025 05:26
If you want to leave a comment, then you need Login or Register





Other news for BMY

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....

BMYApril 10, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Forecast Target with 8.57% Profit: A Success Story for QuantWave  ~2 min.

BRISTOL-MYERS SQUIBB COMPANY (BMY) recently reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors....



Related news

ABBVDecember 4, 2024ABBVIE INC.: A Leading Pharmaceutical Company with High Institutional Ownership  ~2 min.

AbbVie Inc. (NYSE: ABBV) is gaining attention in the investment world due to its high institutional ownership....

AZNDecember 10, 2024AstraZeneca PLC: A Leading Pharmaceutical Company with Strong Momentum  ~2 min.

AstraZeneca PLC (AZN) is a renowned pharmaceutical company that has been experiencing strong momentum in the market....

CSCODecember 13, 2024Billionaire Asness Sold Cisco Systems CSCO and Bought Eli Lilly and Company LLY  ~2 min.

Cisco Systems Inc. (NASDAQ: CSCO) recently witnessed a significant change in its stock ownership as billionaire investor Cliff Asness sold his shares in the company....

ABBVJanuary 9, 2025AbbVie Inc. NYSE:ABBV Captivates Institutional Shareholders with 73% Ownership  ~2 min.

AbbVie Inc., the renowned pharmaceutical company listed on NYSE under the ticker symbol ABBV, boasts an impressive 73% ownership by institutional shareholders....

SBACJanuary 2, 2025SBA Communications Co. Surges as JPMorgan Chase Co. Increases Ownership  ~2 min.

SBA Communications Corporation (NASDAQ: SBAC) witnessed a significant boost in its shares as JPMorgan Chase & Co. increased its ownership in the company....